Literature DB >> 8080819

Angiotensin II receptor pharmacology.

K K Griendling1, B Lassègue, T J Murphy, R W Alexander.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8080819     DOI: 10.1016/s1054-3589(08)60498-6

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN: 1054-3589


× No keyword cloud information.
  12 in total

1.  The inducible cAMP early repressor ICERIIgamma inhibits CREB and AP-1 transcription but not AT1 receptor gene expression in vascular smooth muscle cells.

Authors:  X Wang; T J Murphy
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

Review 2.  The role of tyrosine phosphorylation in angiotensin II mediated intracellular signaling and cell growth.

Authors:  B Schieffer; K E Bernstein; M B Marrero
Journal:  J Mol Med (Berl)       Date:  1996-02       Impact factor: 4.599

Review 3.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

4.  Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice.

Authors:  Peiyong Zhai; Mitsutaka Yamamoto; Jonathan Galeotti; Jing Liu; Malthi Masurekar; Jill Thaisz; Keiichi Irie; Eric Holle; Xianzhong Yu; Sabina Kupershmidt; Dan M Roden; Thomas Wagner; Atsuko Yatani; Dorothy E Vatner; Stephen F Vatner; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

5.  Angiotensin II-induced apoptosis in rat cardiomyocyte culture: a possible role of AT1 and AT2 receptors.

Authors:  I Goldenberg; E Grossman; K A Jacobson; V Shneyvays; A Shainberg
Journal:  J Hypertens       Date:  2001-09       Impact factor: 4.844

Review 6.  Angiotensin II receptors and drug discovery in cardiovascular disease.

Authors:  Chiranjib Dasgupta; Lubo Zhang
Journal:  Drug Discov Today       Date:  2010-12-13       Impact factor: 7.851

7.  Reduction of oxidative stress and AT1 receptor expression by the selective oestrogen receptor modulator idoxifene.

Authors:  A T Bäumer; S Wassmann; K Ahlbory; K Strehlow; C Müller; H Sauer; M Böhm; G Nickenig
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

Review 8.  A Review of the Role of Bradykinin and Nitric Oxide in the Cardioprotective Action of Angiotensin-Converting Enzyme Inhibitors: Focus on Perindopril.

Authors:  Arnaud Ancion; Julien Tridetti; Mai-Linh Nguyen Trung; Cécile Oury; Patrizio Lancellotti
Journal:  Cardiol Ther       Date:  2019-10-01

Review 9.  A comprehensive insight into the role of zinc deficiency in the renin-angiotensin and kinin-kallikrein system dysfunctions in COVID-19 patients.

Authors:  Ahmed S Gouda; Fatima G Adbelruhman; Reham N Elbendary; Fadiyah Ahmed Alharbi; Sultan Qalit Alhamrani; Bruno Mégarbane
Journal:  Saudi J Biol Sci       Date:  2021-03-16       Impact factor: 4.219

Review 10.  Snake venom-derived bradykinin-potentiating peptides: A promising therapy for COVID-19?

Authors:  Ahmed S Gouda; Bruno Mégarbane
Journal:  Drug Dev Res       Date:  2020-08-05       Impact factor: 5.004

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.